Physician profile
Nelson Sanchez
NPI 1508942731
$1,338.36
in general payments reported to CMS, 2019-2025
22 companies · $89.43 in 2025
The $89.43 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $123 · 2021: $253 · 2022: $91.52 · 2023: $37.86 · 2024: $48.89 · 2025: $89.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $176.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greenwich Biosciences, INC. | $258.03 | 2019-2020 | |
| Neurelis, INC. | $221.71 | 2021-2025 | Valtoco |
| Shire North American Group INC | $117.41 | 2019 | |
| Allergan, INC. | $97.33 | 2019 | |
| Galderma Laboratories, L.P. | $84.87 | 2020 | |
| Novartis Pharmaceuticals Corporation | $64.19 | 2019-2021 | |
| Lilly USA, LLC | $61.24 | 2025 | Zepbound, Mounjaro |
| Livanova USA, INC. | $56.49 | 2019 | |
| Tris Pharma INC | $56.21 | 2019-2022 | |
| Inspire Medical Systems, INC. | $48.89 | 2024 | Inspire |
| Sunovion Pharmaceuticals INC. | $45.64 | 2019 | |
| Jazz Pharmaceuticals INC. | $37.86 | 2023 | |
| Supernus Pharmaceuticals, INC. | $36.27 | 2020-2021 | |
| Aprecia Pharmaceuticals, LLC | $25.07 | 2022 | |
| Zogenix INC. | $23.68 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $21.14 | 2021 | |
| Eisai INC. | $20.06 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.77 | 2019 | |
| Cranial Technologies, INC | $16.64 | 2019 | |
| Biogen, INC. | $13.60 | 2019 | |
| Ironshore Pharmaceuticals INC. | $12.26 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nelson Sanchez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.